TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2 - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly
Journal Articles Molecular Cancer Year : 2023

TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2

André Baruchel
  • Function : Author

Abstract

The reintegration of excised signal joints resulting from human V(D)J recombination was described as a potent source of genomic instability in human lymphoid cancers. However, such molecular events have not been recurrently reported in clinical patient lymphoma/leukemia samples. Using a specifically designed NGS-capture pipeline, we here demonstrated the reintegration of T-cell receptor excision circles (TRECs) in 20/1533 (1.3%) patients with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). Remarkably, the reintegration of TREC recurrently targeted the tumor suppressor gene, ZFP36L2, in 17/20 samples. Thus, our data identified a new and hardly detectable mechanism of gene deregulation in lymphoid cancers providing new insights in human oncogenesis.
Fichier principal
Vignette du fichier
Balducci et al 2023.pdf (1.51 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-04237392 , version 1 (11-10-2023)

Identifiers

Cite

Estelle Balducci, Thomas Steimlé, Charlotte Smith, Patrick Villarese, Mélanie Feroul, et al.. TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2. Molecular Cancer, 2023, 22 (1), pp.108. ⟨10.1186/s12943-023-01794-y⟩. ⟨hal-04237392⟩
47 View
15 Download

Altmetric

Share

Gmail Facebook X LinkedIn More